Mother-to-child transmission of SARS-CoV-2: evaluating the association between preventive measures and the risk of infection
Can't see this email? View it online
   
  Dermatology  
  The latest dermatology news from News Medical  
 Study offers the most comprehensive archive of cellular, molecular features involved in psoriatic diseaseStudy offers the most comprehensive archive of cellular, molecular features involved in psoriatic disease
 
Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, a new study shows.
 
 
 Mother-to-child transmission of SARS-CoV-2: evaluating the association between preventive measures and the risk of infectionMother-to-child transmission of SARS-CoV-2: evaluating the association between preventive measures and the risk of infection
 
Researchers evaluated the mother-to-infant transmission rates of SARS-CoV-2.
 
   Burden of autoimmune disease continues to increase over time, research suggestsBurden of autoimmune disease continues to increase over time, research suggests
 
EULAR – the European Alliance of Associations for Rheumatology – works on a broad spectrum of autoimmune and auto-inflammatory diseases.
 
   High levels of memory killer cells correlate with better survival in melanoma patientsHigh levels of memory killer cells correlate with better survival in melanoma patients
 
Our skin contains specialized long-lived killer cells that protect against intruders. Researchers at Karolinska Institutet in Sweden and the University of Copenhagen in Denmark have now identified how these cells are formed, and shown that high levels of memory killer cells in cancer tissue correlate with a better survival rate in people with melanoma.
 
   Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritisLupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis
 
Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis.
 
 NIH scientists identify genomic variants that cause rare inflammatory skin disorder
 
NIH scientists identify genomic variants that cause rare inflammatory skin disorderResearchers at the National Institutes of Health and their colleagues have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment.
 
 
 Breaking barriers to improve access to quality information about lupus
 
Breaking barriers to improve access to quality information about lupusIn general, there is an issue around the quality of information about lupus on the internet. Rumors, unchecked data, and unconfirmed research all contribute to confusion and anxiety, and can lead to people taking the wrong actions for themselves and their disease.
 
 
 Women taking oral estrogen therapy more likely to develop high blood pressure
 
Women taking oral estrogen therapy more likely to develop high blood pressureWomen ages 45 years and older taking estrogen hormone therapy in pill form were more likely to develop high blood pressure than those using transdermal (topical, applied to the skin) or vaginal formulations, according to new research published today in Hypertension, a peer-reviewed American Heart Association journal.
 
 
 MFAP5, a microfibril-associated protein, unveiled as key player in scar formation and wound healing
 
MFAP5, a microfibril-associated protein, unveiled as key player in scar formation and wound healingMFAP5, a microfibril-associated protein, plays a significant role in wound healing by regulating fibroblast function, collagen deposition, and angiogenesis, suggesting its potential as a modulator of scar formation.
 
 
 Study provides a treasure trove of information on molecular biology of the immune system
 
Study provides a treasure trove of information on molecular biology of the immune systemResearchers at Sanford Burnham Prebys, collaborating with scientists from Eli Lilly and Company, have revealed the structure and function of a drug called LY3361237, which can reduce the harmful activity of the immune system to help treat autoimmune diseases.
 
 
 Effects of KMC in preterm and low birth weight infants
 
Effects of KMC in preterm and low birth weight infantsA method of care involving skin-to-skin contact between a mother and her prematurely born or low birth weight baby appears to impact the child's chances of survival significantly, suggests a study published online in the journal BMJ Global Health.